Multivariate analyses of prognostic factors for PFS and OS in patients newly diagnosed with MM (N = 1252), including the presence of MDS-PA based on aberrant CD56 expression in the monocytic lineage
| Variable . | PFS . | OS . | ||
|---|---|---|---|---|
| HR (95% CI) . | P . | HR (95% CI) . | P . | |
| ISS stage III | 1.3 (1.0-1.6) | .029 | 1.7 (1.3-2.1) | .000 × 104 |
| Elevated LDH levels | 1.7 (1.3-2.2) | .00 | 1.9 (1.4-2.6) | .000 × 105 |
| t(4;14), t(14;16), del(17p) | 1.3 (1.1-1.6) | .009 | 1.5 (1.2-1.9) | .000 × 104 |
| MDS-PA | 1.5 (1.1-2.1) | .016 | 1.7 (1.1-2.5) | .012 |
| Variable . | PFS . | OS . | ||
|---|---|---|---|---|
| HR (95% CI) . | P . | HR (95% CI) . | P . | |
| ISS stage III | 1.3 (1.0-1.6) | .029 | 1.7 (1.3-2.1) | .000 × 104 |
| Elevated LDH levels | 1.7 (1.3-2.2) | .00 | 1.9 (1.4-2.6) | .000 × 105 |
| t(4;14), t(14;16), del(17p) | 1.3 (1.1-1.6) | .009 | 1.5 (1.2-1.9) | .000 × 104 |
| MDS-PA | 1.5 (1.1-2.1) | .016 | 1.7 (1.1-2.5) | .012 |
LDH, lactate dehydrogenase.